Corleen Roche
Fortuna: 124 580 $ al 31/05/2026
Fortuna: 124 580 $ al 31/05/2026
Corleen M.
Roche is Chief Financial & Accounting Officer at Iovance Biotherapeutics, Inc. since 2025.
Formerly, Ms. Roche was Secretary, Chief Financial & Accounting Officer at CG Oncology, Inc. from 2024 to 2025; Chief Financial & Accounting Officer at Immunome, Inc. from 2021 to 2024; Chief Financial Officer at Iogenetics LLC; Chief Financial Officer at CSL Behring LLC; Chief Financial Officer at Biogen, Inc. from 2019 to 2021; Chief Financial Officer at Sandoz, Inc. from 2015 to 2019; Chief Financial Officer at Wyeth Pharmaceuticals, Inc.; and Chief Financial Officer at Pfizer Inc. Ms. Roche completed undergraduate studies at Villanova University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/03/2026 | 2.000 ( 0 % ) | 124 580 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Director Financiero/CFO | 06/08/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| CG ONCOLOGY, INC. | Director Financiero/CFO | 05/08/2025 |
| IMMUNOME, INC. | Director Financiero/CFO | 02/01/2024 |
| BIOGEN INC. | Director Financiero/CFO | 01/04/2021 |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Director Financiero/CFO | 01/01/2019 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Iogenetics LLC
Iogenetics LLC Miscellaneous Commercial ServicesCommercial Services Develops proprietary antimicrobial proteins and immunogenetics solutions | Commercial Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
CG Oncology, Inc.
CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.